

Ron Cornell
8.1K posts

@RonaldCornell
Product Management @ Moderna | #Healthcare Strategy & #Innovation #DigitalHealth, #MachineLearning #AI #NorthwesternUniversity #Pharma







Moderna and @Merck today announced that mRNA-4157 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, demonstrated sustained improvement in recurrence-free survival and distant metastasis-free survival compared with KEYTRUDA alone in patients with high-risk stage III/IV melanoma following complete resection. These data are being presented for the first time today during a rapid oral abstract session at the 2024 @ASCO Annual Meeting (abstract hashtag#LBA9512). Learn more: investors.modernatx.com/news/news-deta…




















